Study: Cancer patients benefit from Phase I drugs

A new study published in the journal Clinical Cancer Research has found that patients with terminal head and neck cancer survived just as well on unapproved, Phase I treatments as FDA-approved drugs. A team headed by University of Texas M.D. Anderson Cancer Center researcher Dr. Ignacio Garrido-Laguna followed 61 patients over five years who'd participated in an early-stage trial. Fifty-nine of them had previously received an FDA-approved treatment for their cancer. The group compared...